Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor In Vitro and In Vivo

Curcumin (Cur) exhibits biological activities that support its candidacy for cancer treatment. However, there are limitations to its pharmacological effects, such as poor solubility and bioavailability. Notably, the use of Cur analogs has potential for addressing these limitations. Dehydrozingerone...

Descripción completa

Detalles Bibliográficos
Autores principales: Mapoung, Sariya, Suzuki, Shugo, Fuji, Satoshi, Naiki-Ito, Aya, Kato, Hiroyuki, Yodkeeree, Supachai, Sakorn, Natee, Ovatlarnporn, Chitchamai, Takahashi, Satoru, Limtrakul (Dejkriengkraikul), Pornngarm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356390/
https://www.ncbi.nlm.nih.gov/pubmed/32545675
http://dx.doi.org/10.3390/molecules25122737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356390/
https://www.ncbi.nlm.nih.gov/pubmed/32545675
http://dx.doi.org/10.3390/molecules25122737

Ejemplares similares